1478877

ORLISTAT RELATED COMPOUND D SOLUTION

United States Pharmacopeia (USP) Reference Standard

• Sinonimo/i: N-Formyl-L-leucine (3S,4R,6S)-3-hexyl-2-oxo-6-undecyltetrahydro-2H-pyran-4-yl ester
• Formula empirica (notazione di Hill): C₂₉H₅₃NO₅
• Numero CAS: 130793-27-0
• Peso molecolare: 495.73
• MDL number: MFCD28137837
• UNSPSC Code: 41116107
• NACRES: NA.24

Proprietà

• grade: pharmaceutical primary standard
• agency: USP
• API family: orlistat
• manufacturer/tradename: USP
• application(s): pharmaceutical
• format: neat
• SMILES string: N([C@@H](CC(C)C)C(=O)O[C@H]1[C@@H](C(=O)O[C@H](C1)CCCCCCCCCCC)CCCCCC)C=O
• InChI: 1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24-21-27(25(28(32)34-24)19-17-10-8-6-2)35-29(33)26(30-22-31)20-23(3)4/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27+/m0/s1
• InChI key: IYWNIYFHQZQPBP-YIPNQBBMSA-N

Descrizione

General description

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

Application

Orlistat Related Compound Solution USP Reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Orlistat
• Orlistat Capsules

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

Informazioni sulla sicurezza

• pictograms: GHS02,GHS07
• signalword: Danger
• hcodes: H225,H302 + H312 + H332,H319
• pcodes: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312 - P305 + P351 + P338
• Hazard Classifications: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2
• Classe di stoccaggio: 3 - Flammable liquids
• flash_point_f: 35.6 °F - closed cup
• flash_point_c: 2.0 °C - closed cup